封面
市场调查报告书
商品编码
1378597

整形外科再生医学市场:按类型、应用和地区划分

Orthopedic Regenerative Medicine Market, By Type, By Application, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到2023年,全球整形外科再生医学市场将达到95.3亿美元,并预计在预测期内(2023-2030年)年复合成长率为10.7%。

报告范围 报告详情
基准年 2022年 2023年市场规模 95.3亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 10.70% 2030年市场规模预测 193.9亿美元
图 1. 2023 年整形外科再生医学按应用分類的全球市场占有率(%)
骨科再生医学市场-IMG1

整形外科再生医学是治疗方法,整形外科专家使用它来:治疗某些整形外科疾病的疼痛和缓解疼痛,例如早期骨关节炎;它可以帮助缓解其他症状并延迟手术的需要。再生整形外科治疗涉及提取、製备人体自然产生的治疗化合物并将其註射到需要治疗的区域。骨科生物製药可用于治疗退化性疾病,例如某些类型的关节炎,以及运动伤害和创伤。再生医学使一些患者可以完全避免整形外科手术。再生整形外科可改善肌肉骨骼系统的疼痛和不适,并治癒肌腱、韧带、骨骼、肌肉、椎间盘、膝半月软骨、软骨和其他肌肉骨骼组织损伤等整形外科病症。身体的大部分区域的自癒能力相对较低。再生医学背后的想法是帮助这些组织更好地癒合。

市场动态

预计主要市场参与者增加的产品推出将在预测期内推动全球整形外科再生医学市场的成长。例如,2020 年 6 月,商业阶段的再生医学公司 Aziyo Biologics, Inc. 宣布推出其最新的 OsteGro 系列产品,该公司致力于开发下一代差异化产品,改善接受外科手术的患者的治疗效果。OsteGro V . OsteGro V 是一种活细胞骨基质,包含鬆质骨颗粒以及去矿物质皮质骨颗粒和纤维,以增强产品处理能力。该产品经过最佳化,可透过 Aziyo Biologics, Inc. 的专有工艺保护和保存天然骨细胞。

本研究的主要特点

  • 本报告对全球整形外科再生医学市场进行了详细分析,并提出了以2022年为基准年的预测期(2023-2030年)的市场规模和復合年度(年复合成长率)。
  • 它还强调了各个细分市场的潜在收益成长机会,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数,介绍了全球整形外科再生医学市场的主要企业。
  • 本研究涵盖的主要企业包括Anika Therapeutics, Inc.、Arthrex, Inc.、Baxter International, Inc.、CONMED Corporation、Johnson &Johnson、Medtronic, Plc、Smith & Nephew plc、Orthofix、Stryker Corporation、Zimmer Holdings, Inc.、 Aziyo Biologics、Ortho Rgenesis Technologies Inc. 和 OssDsign。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 整形外科再生医学全球市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球整形外科再生医学市场的各种策略矩阵来促进决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 近期产品发布
  • 流行病学
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • PEST分析

第4章全球整形外科再生医学市场-新型冠状病毒感染疾病(COVID-19)的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 对需求和供给的影响

第5章2018-2030年全球整形外科再生医学市场(按类型)

  • 干细胞
  • 生物材料
  • 人体组织工程

第6章全球整形外科再生医学市场,依应用分类,2018-2030

  • 骨关节疾病
  • 类风湿性关节炎
  • 韧带损伤
  • 黏液囊炎
  • 骨质疏鬆症
  • 其他的

第7章2018-2030年全球整形外科再生医学市场(按地区)

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第8章竞争形势

  • 公司简介
    • Anika Therapeutics, Inc
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • Johnson &Johnson
    • Medtronic, Plc
    • Smith &Nephew plc
    • Orthofix
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.
    • OssDsign.

第9章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI4841

The Global Orthopedic Regenerative Medicine Market is estimated to be valued at US$ 9.53 billion in 2023, and is expected to exhibit a CAGR of 10.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.53 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.70% 2030 Value Projection: US$ 19.39 Bn
Figure 1. Global Orthopedic Regenerative Medicine Market Share (%), By Application, 2023
Orthopedic Regenerative Medicine Market - IMG1

Orthopedic regenerative medicine are therapies developed from biologic (natural) substances that can be used by orthopaedic specialists to: Help relieve pain and other symptoms of certain orthopaedic conditions, such as early osteoarthritis, which may help delay the need for surgery. With regenerative orthopedic therapy, healing elements that the body naturally produces are extracted, prepared, and then injected into the areas of the body that need healing, all without drugs or surgery. Orthobiologics can be used to treat degenerative conditions such as certain forms of arthritis, as well as sports injuries and traumas. Regenerative medicine may help some patients avoid orthopedic surgery completely. Regenerative orthopedics may improve pain and discomfort of the musculoskeletal system and enhance the healing of orthopedic conditions, such as injuries of a tendon, ligament, bone, muscle, spinal disc, meniscus of the knee, cartilage or other musculoskeletal tissue. Most of these parts of the body have a relatively poor ability to heal on their own. The idea behind regenerative medicine is to help these tissues heal better.

Market Dynamics

Increasing product launches by the key players in the market are expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, in June 2020, Aziyo Biologics, Inc., a commercial-stage regenerative medicine company creating the next generation of differentiated products to improve outcomes in patients undergoing surgery, announced the launch of its newest OsteGro family product, OsteGro V, a viable cell bone matrix containing cancellous bone particles as well as demineralized cortical bone particles and fibers to enhance product handling. The product is optimized to protect and preserve native bone cells through Aziyo Biologics, Inc.'s proprietary process.

Key features of the study:

  • This report provides an in-depth analysis of the global orthopedic regenerative medicine market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global orthopedic regenerative medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Te key companies covered as a part of this study include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Orthofix, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc., OssDsign
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global orthopedic regenerative medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthopedic regenerative medicine market

Global Orthopedic Regenerative Medicine Market Detailed Segmentation:

  • By Type:
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • By Application:
    • Osteoarticular Diseases
    • Rheumatoid Arthritis
    • Ligament Injuries
    • Burisitis
    • Osteoporosis
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Anika Therapeutics, Inc
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • Johnson & Johnson
    • Medtronic, Plc
    • Smith & Nephew plc
    • Orthofix
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.
    • OssDsign.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Orthopedic Regenerative Medicine Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Orthopedic Regenerative Medicine Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Stem Cell
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Biomaterial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

6. Global Orthopedic Regenerative Medicine Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Osteoarticular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Rheumatoid Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Ligament Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Burisitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Osteoporosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global Orthopedic Regenerative Medicine Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Company Profiles
    • Anika Therapeutics, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Arthrex, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Baxter International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • CONMED Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Medtronic, Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Smith & Nephew plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Orthofix
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Stryker Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Zimmer Holdings, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Aziyo Biologics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Ortho Regenerative Technologies Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • OssDsign.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact